美国研究人员日前报告说:他们开发出一种实验性猿类免疫缺陷病毒疫苗,可大幅降低恒河猴感染猿类艾滋病病毒的风险。这一研究成果为开发人类艾滋病疫苗提供了新思路。这项由哈佛大学医学院等机构参与、美国国家过敏和传染病研究所资助的研究显示,与注射安慰剂疫苗的恒河猴相比,注射实验性疫苗的恒河猴感染猿类免疫缺陷病毒(sI v)的风险低80%。反复接触病毒后,大部分注射疫苗的恒河猴最终感染猿类免疫缺陷病毒,即猿类艾滋病病毒,但血液 US researchers recently reported that they have developed an experimental apes immunodeficiency virus vaccine, can significantly reduce the risk of rhesus monkeys infected with apes AIDS virus. This research provides a new idea for developing human AIDS vaccine. The study, funded by institutions such as Harvard Medical School and funded by the National Institute of Allergy and Infectious Diseases, showed that rhesus monkeys injected with the experimental vaccine were infected with the apes-like immunodeficiency virus compared with rhesus monkeys injected with a placebo vaccine (sI v) is 80% less risky. After repeated exposure to the virus, most of the vaccine-injected rhesus monkeys eventually become infected with the apes immunodeficiency virus, apes, but the blood